This inventor holds 4 USPTO granted patents and 10 published patent applications and 1 EPO patent. Top assignee: Maze Therapeutics, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Contributions of Patrick Sang Tae Lee
Introduction
Patrick Sang Tae Lee is a notable inventor based in Walnut Creek, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of three patents to his name, Lee's work is paving the way for advancements in medical treatments.
Latest Patents
Among his latest patents, Lee has developed APOL1 inhibitors and methods of use. These patents include compounds of formula (II) and provide methods for preparing these compounds, as well as methods for inhibiting APOL1. His work focuses on treating APOL1-mediated diseases, disorders, or conditions in individuals, showcasing his commitment to improving health outcomes.
Career Highlights
Patrick Lee is currently associated with Maze Therapeutics, Inc., where he continues to innovate and contribute to the field of medicine. His expertise and dedication have positioned him as a key player in the development of new therapeutic strategies.
Collaborations
Lee collaborates with talented individuals in his field, including David John Morgans, Jr. and Christopher Joseph Sinz. These partnerships enhance the research and development process, leading to more effective solutions in healthcare.
Conclusion
Patrick Sang Tae Lee's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are making a significant impact on the treatment of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile